Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.
ONCOLOGY Vol 36, Issue 8
P. Connor Johnson, MD, and Jeremy S. Abramson MD, MMSc, discuss available treatments for patients with Burkitt lymphoma and high-grade B-cell lymphoma.
“...we don’t focus on survivorship enough. It’s important to understand the other factors involved in surviving besides just a treatment.”
ONCOLOGY Co-Editor-in-Chief Julie M. Vose, MD, MBA, explores high drug costs and financial toxicity.
Advertisement
Advertisement
Trending on CancerNetwork
1
Resecting MRI-Detected Disease Doesn’t Improve Outcomes in Early-Stage BC
2
Pembrolizumab/Radiation Improves T Cell Infiltration in Early Breast Cancer
3
Nivolumab/AVD Receives FDA Priority Review in Classical Hodgkin Lymphoma
4
Sacituzumab Govitecan Does Not Meet Statistical Significance in HR+/HER2– mBC
5
